Houston Neuromonitoring is categorized under Internal Medicine Doctors in Houston, TX and active since 2006.
Houston Neuromonitoring was established in 2006, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Nancy Maisel, Office Manager at the company’s single location by writing to 3433 Wickersham Lane, Houston, Texas TX 77027 or by phoning (713) 791-9778. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Houston Neuromonitoring |
| Contact Person: | Nancy Maisel, Office Manager |
| Address: | 3433 Wickersham Lane, Houston, Texas 77027 |
| Phone Number: | (713) 791-9778 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Houston Neuromonitoring was started in 2006 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Nancy Maisel, Office Manager for inquiries that concern Houston Neuromonitoring by calling the company number (713) 791-9778, as your correspondence is most welcome. Additionally, the physical location of the single location of Houston Neuromonitoring can be found at the coordinates 29.74328,-95.431628 as well as the street address 3433 Wickersham Lane in Houston, Texas 77027.
For its online presence, you may visit Houston Neuromonitoring’s website at and engage with its social media outlets through on Twitter and on Facebook.